Global Canine Arthritis Treatment Market Analysis 2025–2029: Opportunities for Strategic Growth
Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
How Much Was The Canine Arthritis Treatment Market Worth In 2025, And What Is Its Anticipated Value By 2029?
The market for canine arthritis treatment has experienced robust expansion in recent times. Projections indicate it will expand from $2.35 billion in 2024 to $2.47 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 5.3%. Factors contributing to this historical expansion include an aging pet population, heightened awareness among pet owners, an emphasis on preventive care, rising disposable income, and increased spending on veterinary services.
The canine arthritis treatment market is projected to experience robust expansion over the coming years, anticipated to reach $3.01 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 5.0%. Factors contributing to this growth during the projection period include increased pet insurance adoption, a rise in arthritis diagnoses, higher rates of pet ownership, an increasing need for less invasive surgical options, and the rising occurrence of arthritis among dogs. Significant trends expected in the forecast timeframe encompass novel treatments, progress in veterinary medicine, a call for sophisticated therapies, technological integration, and cutting-edge innovations.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16007&type=smp
What Are The Main Drivers Boosting The Canine Arthritis Treatment Industry’s Expansion?
Increased pet ownership is projected to drive the expansion of the canine arthritis treatment market moving forward. Pet ownership involves the care and responsibility undertaken by individuals or households in providing for the companionship, well-being, and needs of domesticated animals kept mainly for enjoyment rather than for practical use. The increase in pet ownership rates stems from factors such as lifestyle adjustments, the humanization of pets, and higher disposable incomes. Pet owners utilize canine arthritis treatments to alleviate and manage arthritis symptoms in their dogs, with the goal of improving their pets’ quality of life and maintaining mobility. For instance, in October 2023, according to the American Pet Products Association, a US-based non-profit association, there were 86.9 million US households that owned a pet, which constituted 66% of households in 2022. Consequently, the rising pet ownership rate is a key driver for the growth of the canine arthritis treatment market.
How Is The Canine Arthritis Treatment Market Classified Into Different Segments?
The canine arthritis treatment market covered in this report is segmented –
1) By Treatment Type: Drugs, Supplements, Surgical Procedures, Other Treatment Types
2) By Route Of Administration: Oral, Parenteral, Other Routes Of Administrations
3) By Arthritis Type: Osteoarthritis, Rheumatoid Arthritis, Osteochondrosis, Traumatic Arthritis
4) By Distribution Channels: Veterinary Clinics And Hospitals, Retail Pharmacies, Online Pharmacies
Subsegments:
1) By Drugs: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Disease-Modifying Osteoarthritis Drugs (DMOADs), Corticosteroids, Analgesics And Pain Relievers
2) By Supplements: Glucosamine And Chondroitin Supplements, Omega-3 Fatty Acids And Fish Oil, Hyaluronic Acid Supplements, MSM (Methylsulfonylmethane) Supplements, Collagen-Based Supplements
3) By Surgical Procedures: Joint Replacement Surgery, Arthroscopy, Osteotomy, Synovectomy
4) By Other Treatment Types: Physical Therapy, Stem Cell Therapy, Platelet-Rich Plasma (PRP) Therapy, Cold Laser Therapy (Low-Level Laser Therapy), Acupuncture
What Trends Are Expected To Drive The Canine Arthritis Treatment Market?
Leading companies in the canine arthritis treatment market are advancing innovative therapies, such as bedinvetmab injections, to enhance canine joint health and mobility. Bedinvetmab is a monoclonal antibody injection designed to target and neutralize nerve growth factor (NGF), a protein implicated in pain within veterinary medicine. For instance, in May 2023, the US-based animal health firm, Zoetis Inc., obtained approval from the Food and Drug Administration (FDA) for Librela, a bedinvetmab injection. This marks the FDA’s initial approval of a monoclonal antibody (mAb) for use in dogs; it functions by binding to and inhibiting the biological activity of canine nerve growth factor (NGF), which is involved in regulating pain associated with OA. Administered as a subcutaneous injection once a month, it offers a convenient and lasting solution for managing canine OA pain.
Who Are The Core Companies Influencing The Canine Arthritis Treatment Market Landscape?
Major companies operating in the canine arthritis treatment market are Merck & Co. Inc., Bayer AG, Eli Lilly and Company, Zoetis Inc., Boehringer Ingelheim Animal Health, Elanco Animal Health Incorporated, Royal Canin SAS, Virbac Group, Ceva Sante Animale S.A., Hill’s Pet Nutrition Inc., Vetoquinol SA, Norbrook Laboratories Limited, American Regent Inc., Thorne Healthtech Inc., VetStem Inc., Eltech K-Laser s.r.l., Liquid Health Inc, Nutri-Vet LLC, OrthoPets LLC, Rejuvenate Bio Inc.
Download The Full Report For Exclusive Market Findings:
https://www.thebusinessresearchcompany.com/report/canine-arthritis-treatment-global-market-report
Which Global Regions Are Influencing The Competitive Landscape Of The Canine Arthritis Treatment Market?
North America was the largest region in the canine arthritis treatment market in 2024. Asia-Pacifica is expected to be the fastest-growing region in the forecast period. The regions covered in the canine arthritis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Canine Arthritis Treatment Market Report:
https://www.thebusinessresearchcompany.com/customise?id=16007&type=smp
Browse Through More Reports Similar to the Global Canine Arthritis Treatment Market 2025, By The Business Research Company
Fertility Treatments Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/fertility-treatments-global-market-report
Polycystic Ovarian Syndrome Treatment Global Market Report 2025
Alzheimer Disease Treatment Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/alzheimer-disease-treatment-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
